Cargando…

Borderline resectable pancreatic cancer: Certainties and controversies

Borderline resectable (BR) pancreatic ductal adenocarcinoma (PDAC) is currently a well-recognized entity, characterized by some specific anatomic, biological and conditional features: It includes patients with a stage of disease intermediate between the resectable and the locally advanced ones. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nappo, Gennaro, Donisi, Greta, Zerbi, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Opinion Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223708/ https://www.ncbi.nlm.nih.gov/pubmed/34194610 http://dx.doi.org/10.4240/wjgs.v13.i6.516

Ejemplares similares

The borderline resectable/locally advanced pancreatic ductal adenocarcinoma: What should be the surgeon's choice?
por: Zerbi, Alessandro, et al.
Publicado: (2017)

Early Recurrence after Upfront Surgery for Pancreatic Ductal Adenocarcinoma
por: Nappo, Gennaro, et al.
Publicado: (2023)

Enhanced Recovery After Pancreatic Surgery Does One Size Really Fit All? A Clinical Score to Predict the Failure of an Enhanced Recovery Protocol After Pancreaticoduodenectomy
por: Capretti, Giovanni, et al.
Publicado: (2020)

Controversies in the Management of Borderline Resectable Proximal Pancreatic Adenocarcinoma with Vascular Involvement
por: Tucker, Olga N., et al.
Publicado: (2008)

Controversies in borderline ovarian tumors
por: Seong, Seok Ju, et al.
Publicado: (2015)

Borderline Resectable Pancreatic Cancer: Challenges for Clinical Management
por: Fawaz, Ali, et al.
Publicado: (2022)

Cholesterol-Dependent Cytolysins Produced by Vaginal Bacteria: Certainties and Controversies
por: Pleckaityte, Milda
Publicado: (2020)

Cutting‐edge strategies for borderline resectable pancreatic cancer
por: Shinde, Rajesh S., et al.
Publicado: (2019)

The Choice of the Most Appropriate Suture Threads for Pancreatic Anastomoses on the Basis of Their Mechanical Characteristics
por: Pagnanelli, Michele, et al.
Publicado: (2023)

Contemporary Review of Borderline Resectable Pancreatic Ductal Adenocarcinoma
por: Bonds, Morgan, et al.
Publicado: (2019)

Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer
por: Janssen, Quisette P., et al.
Publicado: (2020)

Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer
por: Massani, Marco, et al.
Publicado: (2023)

Issues and controversies in esophageal inlet patch
por: Ciocalteu, Adriana, et al.
Publicado: (2019)

Contemporary management of borderline resectable pancreatic ductal adenocarcinoma
por: Lekka, Kyriaki, et al.
Publicado: (2019)

Ampullary Cancer: Histological Subtypes, Markers, and Clinical Behaviour—State of the Art and Perspectives
por: Nappo, Gennaro, et al.
Publicado: (2023)

Complex genetic diseases: controversy over the Croesus code
por: Wright, Alan F, et al.
Publicado: (2001)

Probiotics for preterm infants – time to end all controversies
por: Athalye‐Jape, Gayatri, et al.
Publicado: (2019)

Acute-on-chronic liver failure: Controversies and consensus
por: Ngu, Natalie L Y, et al.
Publicado: (2023)

Perioperative Predictors of Early Recurrence for Resectable and Borderline-Resectable Pancreatic Cancer
por: Imamura, Masafumi, et al.
Publicado: (2021)

Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy
por: Mikulic, Danko, et al.
Publicado: (2021)

Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
por: Versteijne, Eva, et al.
Publicado: (2022)

Comprehensive multimodal management of borderline resectable pancreatic cancer: Current status and progress
por: Wu, Hong-Yu, et al.
Publicado: (2023)

Advances and controversies in the management of early stage non-small cell lung cancer
por: Cilleruelo-Ramos, Angel, et al.
Publicado: (2021)

Borderline tumours of the ovary, current controversies regarding their diagnosis and treatment
por: Patrono, María Guadalupe, et al.
Publicado: (2013)

How A Patient with Resectable or Borderline Resectable Pancreatic Cancer should Be Treated—A Comprehensive Review
por: Kwaśniewska, Daria, et al.
Publicado: (2023)

The identification of the Romanovs: Can we (finally) put the controversies to rest?
por: Coble, Michael D
Publicado: (2011)

Meta‐analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer
por: Versteijne, E., et al.
Publicado: (2018)

Optimizing neoadjuvant radiotherapy for resectable and borderline resectable pancreatic cancer using protons
por: Nichols, Romaine Charles, et al.
Publicado: (2019)

Pancreatic serous cystoadenoma (CSA) showing increased tracer uptake at 68-GaDOTA-peptide Positron Emission Tomography (68Ga-DOTA-peptide PET-CT): a case report
por: Nappo, Gennaro, et al.
Publicado: (2020)

Optimal Preoperative Multidisciplinary Treatment in Borderline Resectable Pancreatic Cancer
por: Kimura, Nana, et al.
Publicado: (2020)

TRIANGLE operation for borderline resectable pancreatic cancer in total pancreatectomy
por: Zhai, Shuyu, et al.
Publicado: (2019)

Updates on adjuvant and neoadjuvant treatment strategies for surgically resectable and borderline resectable pancreatic ductal adenocarcinoma
por: Iyengar, Siddharth, et al.
Publicado: (2021)

Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine
por: Vernuccio, Federica, et al.
Publicado: (2021)

International assessment and validation of the prognostic role of lymph node ratio in patients with resected pancreatic head ductal adenocarcinoma
por: Joliat, Gaëtan-Romain, et al.
Publicado: (2022)

Neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma: The need for patient-centered research
por: Cloyd, Jordan M, et al.
Publicado: (2020)

Observation or resection of pancreatic intraductal papillary mucinous neoplasm: An ongoing tug of war
por: Aunan, Jan Rune, et al.
Publicado: (2019)

The Paradox of Nuclear Lamins in Pathologies: Apparently Controversial Roles Explained by Tissue-Specific Mechanobiology
por: Urciuoli, Enrica, et al.
Publicado: (2022)

The past, present, and future status of multimodality treatment for resectable/borderline resectable pancreatic ductal adenocarcinoma
por: Sakaguchi, Tatsuma, et al.
Publicado: (2020)

Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
por: Alva-Ruiz, Roberto, et al.
Publicado: (2021)

Validation of Group B Borderline Resectable Pancreatic Cancer: Retrospective Analysis
por: Oh, Tak Geun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qarbjeadb5g5edvkt3q21inl5o